15.14
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By c…
Pharmacodynamic models are broadly categorized as direct effect or indirect response models.
Direct effect models link drug concentration to response for drugs rapidly reaching their site of action.
The response may be proportional to concentration in a linear model, or follow an Emax model.
For example, argatroban's plasma concentrations directly relate to its anticoagulant response, which follows an Emax model.
Indirect response models describe how a drug influences the production or elimination of endogenous compounds.
For instance, models I and II describe inhibitory effects on response production and degradation, with Imax capped between 0 and 1. In contrast, models III and IV describe stimulatory effects, with the maximum stimulation value always greater than 0.
These models often display a delayed peak response, gradual response changes, initial rates independent of dose, and a prolonged time to maximum effect at higher doses.
They support dose selection and help assess early drug candidates during development. One example is modeling mizolastine's antihistaminic effect on flare area over time at varying doses.
View the full transcript and gain access to JoVE Core videos
Q1: What is the difference between direct effect and indirect response pharmacodynamic models?
Direct effect models link drug concentration directly to response for drugs rapidly reaching their site of action, with response proportional to concentration or following an Emax model. Indirect response models describe how drugs influence production or elimination of endogenous compounds, often displaying delayed peak responses and prolonged time to maximum effect at higher doses.
Q2: How do indirect response models I and II differ from models III and IV?
Models I and II describe inhibitory effects on response production and degradation, with Imax capped between 0 and 1. Models III and IV describe stimulatory effects, with maximum stimulation values always greater than 0, allowing drugs to enhance endogenous compound production or elimination.
Q3: Why do indirect response models show delayed peak responses compared to direct effect models?
Indirect response models show delayed peak responses because drugs influence production or degradation of endogenous substances rather than acting directly at the site of action. This mechanism results in gradual response changes, dose-independent initial rates, and prolonged time to maximum effect, particularly at higher doses.
Q4: What is an example of a drug following a direct effect model?
Argatroban, an anticoagulant, demonstrates a direct effect model where its plasma concentrations directly relate to anticoagulant response following an Emax model. This rapid relationship between drug concentration and pharmacological effect exemplifies drugs that quickly reach their site of action and produce immediate responses.
Q5: How is mizolastine's antihistaminic effect modeled using indirect response methods?
Mizolastine's antihistaminic activity is modeled using indirect response methods to capture its impact on reducing flare area over time across varying doses. This approach reflects the delayed yet sustained effects characteristic of drugs that influence endogenous substance production or degradation rather than acting directly.
Q6: What role do pharmacodynamic models play in drug development and dose selection?
Pharmacodynamic models support dose selection and help assess early drug candidates during development by characterizing the dynamics of drug action. These models guide optimal dosing strategies and inform regulatory decisions by linking drug concentration to biological response, ensuring safer and more effective therapeutic interventions.
Q7: What characteristics distinguish indirect response models from direct effect models in terms of time course?
Indirect response models display gradual response changes, initial rates independent of dose, and prolonged time to maximum effect at higher doses, creating a delayed peak response. Direct effect models show immediate concentration-response relationships without these temporal delays or dose-independent initial rate characteristics.